Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PNC Riverarch Capital is a middle-market private equity firm that invests in privately held, market-leading companies across value-added distribution, business services, and specialized manufacturing, supporting leveraged and management buyouts, corporate divestitures, and growth financings. In 2024 it rebranded to Riverarch Equity Partners and closed its fourth equity fund with $1.0 billion in commitments, continuing the same investment strategy as an affiliate of The PNC Financial Services Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PNC Riverarch Capital.